中美臨床和轉(zhuǎn)化醫(yī)學(xué)論壇 SAS-CTM Sino-American Symposium on Clinical and Translational Medicine  www.transmed.org.cn
臨床和轉(zhuǎn)化醫(yī)學(xué)研究關(guān)系到社會(huì)整體健康水平的發(fā)展, 也同每個(gè)國(guó)際多中心的臨床試驗(yàn)密切相關(guān), 藥物研制創(chuàng)新, 更涉及到從實(shí)驗(yàn)室成果轉(zhuǎn)化成為患者病床前臨床應(yīng)用的全部過(guò)程。

提倡和推進(jìn)轉(zhuǎn)化醫(yī)學(xué)研究是我們所共同關(guān)心的提高醫(yī)藥衛(wèi)生健康服務(wù)質(zhì)量的前提和保障。近年來(lái), 在國(guó)家重大科技專(zhuān)項(xiàng)和地方科技基金支持下,特別是國(guó)家十二五計(jì)劃推動(dòng)和實(shí)施，我國(guó)將迎來(lái)生物醫(yī)藥創(chuàng)新發(fā)展的新高峰?？陀^上, 我國(guó)生物醫(yī)藥產(chǎn)業(yè)的迅猛發(fā)展和巨大的健康產(chǎn)業(yè)市場(chǎng), 構(gòu)成了轉(zhuǎn)化醫(yī)學(xué)研究的最佳環(huán)境。已成立的十多家轉(zhuǎn)化醫(yī)學(xué)中心和數(shù)百家醫(yī)院的臨床試驗(yàn)基地承接著國(guó)際化多中心臨床研究合作，這些在積極推動(dòng)著我國(guó)轉(zhuǎn)化醫(yī)學(xué)發(fā)展的腳步, 預(yù)示著我國(guó)在加快臨床和轉(zhuǎn)化醫(yī)學(xué)學(xué)科建立的進(jìn)程同時(shí)，開(kāi)啟了與國(guó)際接軌的良好開(kāi)端。

預(yù)測(cè)成果轉(zhuǎn)化對(duì)臨床實(shí)踐的影響有著極為重要的現(xiàn)實(shí)意義。

吸納國(guó)際轉(zhuǎn)化醫(yī)學(xué)研究和管理經(jīng)驗(yàn), 提供國(guó)內(nèi)轉(zhuǎn)化醫(yī)學(xué)交流的平臺(tái)。這樣, 我們的科研人員才會(huì)更好地根據(jù)自身的科研資源, 開(kāi)展轉(zhuǎn)化醫(yī)學(xué)的國(guó)際交流與合作。

開(kāi)拓“臨床和轉(zhuǎn)化醫(yī)學(xué)”這個(gè)嶄新領(lǐng)域, 為基礎(chǔ)與臨床科研人員提供國(guó)內(nèi)外轉(zhuǎn)化醫(yī)學(xué)資訊, 導(dǎo)航轉(zhuǎn)化型科研項(xiàng)目,將會(huì)使我們及時(shí)地參考國(guó)際轉(zhuǎn)化醫(yī)學(xué)發(fā)展的路線圖和經(jīng)驗(yàn), 把我們自己的“轉(zhuǎn)化醫(yī)學(xué)” 的腳步走得更踏實(shí), 更有實(shí)際意義。
中美臨床和轉(zhuǎn)化醫(yī)學(xué)論壇 SAS-CTM

2012年中美臨床和轉(zhuǎn)化醫(yī)學(xué)國(guó)際論壇組委會(huì)秘書(shū)處
上海市中國(guó)工程院院士咨詢(xún)與學(xué)術(shù)活動(dòng)中心
聯(lián)系人：劉昕卿、賴(lài)瑾瑾
電 話： 
021-63875151 轉(zhuǎn)668、683
郵 箱： 
sas.ctm@gmail.com
 
上?？萍紩?huì)展有限公司 
聯(lián)系人： 張迅杰 
電 話： 
021- 54065307
郵 箱： 
zxj@stcec.com

Condition, and each international multicenter clinical trial; the innovation of drug development involves the whole process from bench to bedside.
Advocating and promoting translational medicine is the prerequisite and support of developing the quality of medical health service. Recently, supported by the Major National Science-Technology Project and the local science-technology funds, especially the promotion and implement of the 12th five-year national development plan, a new summit of the innovation development of biological medicine will be reached. Objectively, the booming biological medicine and enormous healthcare market cultivate the optimum environment of translational research. More than ten translational research centers and hundreds of clinical centers in the hospitals undertake international and multicenter clinical research collaboration, which makes a good start in connecting to the international while promoting the development of our translational research and indicating that the process of establishing the clinical and translational research science is speeding up.

Predicting the impact of translating research achievements into clinical practice is of great practical and significance.
By exploring this novel domain of Clinical and Translational Research, providing domestic and foreign information of translational research to basic and clinical researchers, and guiding the transformed science and technology research projects, we’ll have a great chance to get the information for reference about the roadmap and experience in the development from international colleagues in time, therefore we can have our own clear and practical footprints of translational medicine.